Investigational gene therapy shows benefits in two boys with DMD
An investigational gene therapy called GNT0004Â has demonstrated sustained stabilization of motor function at up to two years of follow-up in two boys with Duchenne muscular dystrophy (DMD). The boys received what was determined to be the effective dose of GNT0004, which was developed by Genethon, during the initial…